INM – Leibniz Institute for New Materials
INM – Leibniz Institute for New Materials
Material-Host Interactions
INM – Leibniz Institute for New Materials
Immuno-Materials
ORCID
Staufer Lab
INM – Leibniz Institute for New Materials
Materials Synthetic Biology
Helmholtz Institute for Pharmaceutical Research Saarland
HIPS – Helmholtz Institute for Pharmaceutical Research
Anti-Infectives from Microbiota
HIPS – Helmholtz Institute for Pharmaceutical Research
Drug Bioinformatics
Saarland University
Saarland University Hospital
Internal Medicine V
Saarland University
Experimental Physics
ORCID
Saarland University
Clinical Experimental Surgery
Saarland University
Pharmaceutical Biotechnology
Saarland University Hospital
Clinic for Ophthalmology
Saarland University
Genetics/Epigenetics
Saarland University
Virology
Saarland University Hospital
Clinic for Gynecology, Obstetrics, and Reproductive Medicine
Saarland University
Systems Biotechnology
Associated Partners
Saarland University Hospital
Medical Microbiology
Technical University Berlin
Institute of Environmental Technology
ORCID
Saarland University Hospital
Urology and Pediatric Urology
Saarland University Hospital
Internal Medicine II
Gastroenterology, Hepatology, Endocrinology, Diabetology, and Nutritional Medicine
Partners of the first funding period
Prof. Dr. Markus Hoth / Saarland University / Biophysics & Immunology
Prof. Dr. Frank Lammert / Medizinische Hochschule Hannover/ Vice President
Prof. Dr. Markus Meyer / Saarland University / Experimental & Clinical Toxicology
Prof. Dr. Albrecht Ott / Saarland University / Biological Experimental Physics
PD Dr. habil. Annette Kraegeloh / INM / Cell Biology & Nanosafety
Prof. Dr. Bin Qu / University of Osnabrück/ Biomedical Foundations
